Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2026-05-19 @ 1:06 PM
Study NCT ID:
NCT04854460
Status:
COMPLETED
Last Update Posted:
2021-04-27
First Post:
2021-04-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study of Ivermectin From Revemact 6 mg Tablets (Man. by EVA Pharma for Horus for Pharmaceutical Industries, Egypt) and Stromectol 2*3 mg Tablets (Merck Sharp & Dohme B.V., Haarlem, The Netherlands)
Sponsor:
Genuine Research Center, Egypt
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GRC/1/21/916
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |